Chronic Pain Syndromes: Complex Regional Pain Syndrome.

Q3 Medicine FP essentials Pub Date : 2023-10-01
Ghena Grinshpun
{"title":"Chronic Pain Syndromes: Complex Regional Pain Syndrome.","authors":"Ghena Grinshpun","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Complex regional pain syndrome (CRPS) is a chronic pain condition characterized by intense pain, usually in a body region that has experienced trauma, and autonomic and inflammatory features. It most commonly develops after an arm or leg injury. Patients typically present with extreme hyperalgesia and/or allodynia. The Budapest Criteria are used to make this clinical diagnosis. Prompt diagnosis and aggressive management are critical because long-term outcomes are improved when treatment is initiated soon after symptom onset. The primary management options are rehabilitation and physical therapy, including such approaches as progressive tactile stimulation, normalization of movement to prevent limited range of motion, and others. No drugs are approved by the Food and Drug Administration (FDA) for CRPS management, but some evidence supports the use of drugs used to manage other types of neuropathic pain (eg, gabapentin, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors). Nonsteroidal anti-inflammatory drugs also are used, and corticosteroids, bisphosphonates, ketamine, and other drugs can be helpful, particularly for early-stage CRPS. When pain severity prevents patients from participating in rehabilitation, referral to a pain specialist is warranted for consideration of procedural interventions, including sympathetic nerve blockade and spinal cord stimulation.</p>","PeriodicalId":38325,"journal":{"name":"FP essentials","volume":"533 ","pages":"21-26"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"FP essentials","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Complex regional pain syndrome (CRPS) is a chronic pain condition characterized by intense pain, usually in a body region that has experienced trauma, and autonomic and inflammatory features. It most commonly develops after an arm or leg injury. Patients typically present with extreme hyperalgesia and/or allodynia. The Budapest Criteria are used to make this clinical diagnosis. Prompt diagnosis and aggressive management are critical because long-term outcomes are improved when treatment is initiated soon after symptom onset. The primary management options are rehabilitation and physical therapy, including such approaches as progressive tactile stimulation, normalization of movement to prevent limited range of motion, and others. No drugs are approved by the Food and Drug Administration (FDA) for CRPS management, but some evidence supports the use of drugs used to manage other types of neuropathic pain (eg, gabapentin, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors). Nonsteroidal anti-inflammatory drugs also are used, and corticosteroids, bisphosphonates, ketamine, and other drugs can be helpful, particularly for early-stage CRPS. When pain severity prevents patients from participating in rehabilitation, referral to a pain specialist is warranted for consideration of procedural interventions, including sympathetic nerve blockade and spinal cord stimulation.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
慢性疼痛综合征:复杂区域疼痛综合征。
复杂区域疼痛综合征(CRPS)是一种以剧烈疼痛为特征的慢性疼痛,通常发生在经历过创伤的身体区域,具有自主神经和炎症特征。它最常见于手臂或腿部受伤后。患者通常表现为极度痛觉过敏和/或异常性疼痛。布达佩斯标准用于进行临床诊断。及时诊断和积极治疗至关重要,因为在症状出现后不久开始治疗,长期结果会得到改善。主要的管理选择是康复和物理治疗,包括渐进触觉刺激、运动正常化以防止有限的运动范围等方法。美国食品药品监督管理局(FDA)没有批准任何药物用于CRPS治疗,但一些证据支持使用用于治疗其他类型神经性疼痛的药物(如加巴喷丁、三环类抗抑郁药、5-羟色胺-去甲肾上腺素再摄取抑制剂)。也使用非甾体抗炎药,皮质类固醇、双磷酸盐、氯胺酮和其他药物可能会有所帮助,尤其是对早期CRPS。当疼痛严重程度使患者无法参与康复时,有必要转诊给疼痛专家,以考虑程序干预措施,包括交感神经阻断和脊髓刺激。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
FP essentials
FP essentials Medicine-Medicine (all)
CiteScore
1.00
自引率
0.00%
发文量
58
期刊最新文献
Female Pelvic Conditions: Dyspareunia and Vulvodynia. Female Pelvic Conditions: Foreword. Female Pelvic Conditions: Interstitial Cystitis/Bladder Pain Syndrome. Female Pelvic Conditions: Sexually Transmitted Infections. Female Pelvic Conditions: Urinary Incontinence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1